These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16519157)

  • 1. [Expression and implication of cyclooxygenase-2 mRNA in prostate cancer].
    Yang MS; Xia SJ; Liu HT; Sun XW; Han BM; Wu JT; Lu J; Ling GM; Tang XD
    Zhonghua Nan Ke Xue; 2006 Feb; 12(2):159-61. PubMed ID: 16519157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The significance of the expression of cyclooxygenase-2 in bladder transitional cell carcinoma tissues].
    Ren L; Hou SK; He LF; Ye HY; Guan KP
    Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1104-7. PubMed ID: 15498296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantitative detection of DD3 mRNA in prostate cancer tissues by real-time fluorescent quantitative reverse transcription polymerase chain reaction].
    Tao ZH; Mao XL; Wang CH; Chen XD; Yu KY; Weng ZL; Hu YP; Zhang XH; Xie H; Wang OC; Song QT; Li CD; Chen ZG
    Zhonghua Nan Ke Xue; 2007 Feb; 13(2):130-3. PubMed ID: 17345768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic relevance of cyclooxygenase-2 (COX-2) expression in Chinese patients with prostate cancer.
    Bin W; He W; Feng Z; Xiangdong L; Yong C; Lele K; Hongbin Z; Honglin G
    Acta Histochem; 2011 Feb; 113(2):131-6. PubMed ID: 19836060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance].
    Liu BQ; Wu YD; Wei JX; Zhang T; Liu RL; Ma TX
    Zhonghua Nan Ke Xue; 2007 Nov; 13(11):997-1001. PubMed ID: 18077911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR2 expression correlates with prostate cancer progression.
    Lu Y; Cai Z; Xiao G; Liu Y; Keller ET; Yao Z; Zhang J
    J Cell Biochem; 2007 Jun; 101(3):676-85. PubMed ID: 17216598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of TGF-beta1 mRNA in prostate carcinoma tissues and its significance].
    Li ZL; Yang Y; Li ZH; Kong CZ
    Zhonghua Nan Ke Xue; 2005 Jul; 11(7):511-3. PubMed ID: 16078668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse transcriptase-polymerase chain reaction and immunohistochemical studies for detection of prostate stem cell antigen expression in prostate cancer: potential value in molecular staging of prostate cancer.
    Joung JY; Yang SO; Jeong IG; Han KS; Seo HK; Chung J; Park WS; Lee KH
    Int J Urol; 2007 Jul; 14(7):635-43. PubMed ID: 17645609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
    Rabien A; Burkhardt M; Jung M; Fritzsche F; Ringsdorf M; Schicktanz H; Loening SA; Kristiansen G; Jung K
    Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of cyclooxygenase-2 and vascular endothelial growth factor in human prostate cancer and its significance].
    Jin TX; Li XG; Wu WY; Piao DM; Feng JY; Sang J
    Zhonghua Nan Ke Xue; 2006 Mar; 12(3):207-10. PubMed ID: 16597032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cyclooxygenase-2 in prostate carcinoma.
    Yoshimura R; Sano H; Masuda C; Kawamura M; Tsubouchi Y; Chargui J; Yoshimura N; Hla T; Wada S
    Cancer; 2000 Aug; 89(3):589-96. PubMed ID: 10931458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 expression is dependent upon epidermal growth factor receptor expression or activation in androgen independent prostate cancer.
    Jia RP; Xu LW; Su Q; Zhao JH; Li WC; Wang F; Xu Z
    Asian J Androl; 2008 Sep; 10(5):758-64. PubMed ID: 18645679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of apoptosis inhibitor gene Livin in prostate cancer and its clinical implication].
    Song T; Hong BF; Gao JP; Zhang L; Cai W
    Zhonghua Nan Ke Xue; 2008 Jan; 14(1):30-3. PubMed ID: 18297808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of ARA55 mRNA in prostate carcinoma tissues and its significance].
    Yang NQ; Li RS; Li D; Sha JJ; Li P; Wang YX
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):696-9. PubMed ID: 17918707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-human chorionic gonadotropin in semen: a marker for early detection of prostate cancer?
    Daja MM; Aghmesheh M; Ow KT; Rohde PR; Barrow KD; Russell PJ
    Mol Urol; 2000; 4(4):421-7. PubMed ID: 11156711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of nucleostemin in prostate cancer tissues and its clinical significance].
    Liu RL; Xu Y; Zhang ZH; Wang M; Sun JT; Qi SY; Zhang Y; Li SZ
    Zhonghua Nan Ke Xue; 2008 May; 14(5):418-22. PubMed ID: 18572860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
    Zhigang Z; Wenlu S
    Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy.
    Rosner IL; Ravindranath L; Furusato B; Chen Y; Gao C; Cullen J; Sesterhenn IA; McLeod DG; Srivastava S; Petrovics G
    Urology; 2007 Dec; 70(6):1225-9. PubMed ID: 18158066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of COX-2 in different human prostate cancer cell lines and its significance].
    Zhao JH; Jiang YG; Wu CT; Luo Y; Hou Z; He DL
    Zhonghua Nan Ke Xue; 2010 Aug; 16(8):689-92. PubMed ID: 21090342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.